We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePhase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non-Hodgkin lymphoma.AuthorsBarr PM; Fu P; Lazarus HM; Horvath N; Gerson SL; Koc ON; Bahlis NJ; Snell MR; Dowlati A; Cooper BWPublicationBritish journal of haematology, 2009, Vol 147, Issue 1, p89ISSN1365-2141Publication typearticleDOI10.1111/j.1365-2141.2009.07836.x